Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Magainin's Locilex cream not approvable says FDA

July 27, 1999

FDA requests additional data to support n-docosanol NDA

July 27, 1999

Cerus initiates phase III U.S. trial of platelet pathogen inactivation system

July 27, 1999

Licensing/CRADA opportunity from NIH: eosinophil-derived neutralizing agent

July 26, 1999

Quinolone antibiotic-Mg2+ complexes have superior physicochemical/pharmacokinetic properties

July 23, 1999

Gemini Technologies awarded SBIR grant to study 2-5A antisense compound

July 23, 1999

Ro-64-0796/GS-4104: potential drug interactions and beneficial effects in patients with the flu

July 22, 1999

sNDA submitted for AmBisome for cryptococcal meningitis in AIDS patients

July 22, 1999

Sitafloxacin: clinically useful fluoroquinolone

July 22, 1999

Antiherpesvirus agents in the Pharmacia & Upjohn pipeline

July 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...